Transforming Gut Microbiome Science into Life-Changing Diagnostic and Therapeutic Solutions. Learn More Transforming Gut Microbiome Science into Life-Changing Diagnostic and Therapeutic Solutions Learn More Our Solutions First in class evidence-based solutions to treat and prevent human disease by diagnosing and treating dysbiosis. Generating data to develop microbiome-based interventions. I will prevent disease whenever I can, […]
Total raised: $6M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 11.06.2025 | - | $6M | - |
Mentions in press and media 4
| Date | Title | Description |
| 12.06.2025 | 32 Biosciences: Pioneering the Future of Gut Health with $6M Funding | In the bustling landscape of biotechnology, 32 Biosciences stands out like a lighthouse in a storm. Based in North Chicago, this innovative company has recently secured $6 million in funding, propelling its mission to revolutionize gut micr... |
| 11.06.2025 | 32 Biosciences Raises $6M in Funding | 32 Biosciences, a Chicago, IL-based gut microbiome medicine company, raised $6M in funding. Backers were not disclosed. The company intends to use the funds for the continued development of its lead assets. Led by CEO Peter Farmakis, 32 Bio... |
| 10.06.2025 | 32 Biosciences Surpasses Financing Target, Accelerates Toward Series A and FDA Milestones | Microbiome-focused company receives $6 million in funding to advance gut microbiome platform technologies NORTH CHICAGO, Ill.–(BUSINESS WIRE)–June 10, 2025– 32 Biosciences, a leader in the field of gut microbiome medicine, today announced i... |
| - | 32 Biosciences | “Transforming Gut Microbiome Science into Life-Changing Diagnostic and Therapeutic Solutions. Learn More Transforming Gut Microbiome Science into Life-Changing Diagnostic and Therapeutic Solutions Learn More Our Solutions First in class evi... |